Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • QBench Reviews & Ratings
    4.6 out of 5 stars 153 Ratings
    Company Website for QBench
  • Gemini platform Reviews & Ratings
    4.3 out of 5 stars 1,178 Ratings
    Company Website for Gemini platform
  • Cloverleaf Reviews & Ratings
    4.8 out of 5 stars 189 Ratings
    Company Website for Cloverleaf
  • Gushwork Reviews & Ratings
    4.5 out of 5 stars 29 Ratings
    Company Website for Gushwork
  • IONOS Cloud GPU Servers Reviews & Ratings
    4.6 out of 5 stars 45,816 Ratings
    Company Website for IONOS Cloud GPU Servers
  • DialerAI Reviews & Ratings
    4.8 out of 5 stars 5 Ratings
    Company Website for DialerAI
  • Evertune Reviews & Ratings
    5.0 out of 5 stars 1 Rating
    Company Website for Evertune
  • Anaconda Reviews & Ratings
    4.4 out of 5 stars 626 Ratings
    Company Website for Anaconda
  • LTX Reviews & Ratings
    4.4 out of 5 stars 182 Ratings
    Company Website for LTX
  • SearchUnify Reviews & Ratings
    4.5 out of 5 stars 150 Ratings
    Company Website for SearchUnify

What is BenchSci?

Optimize the entire selection process for reagents and model systems to eliminate inefficiencies and reduce errors that can result in costly experimental setbacks. By condensing the decision-making timeframe from the usual 12 weeks to a mere 30 seconds, project timelines can be significantly shortened. This strategy not only minimizes direct expenses associated with consumables but also has the capacity to generate substantial annual savings. In addition, it supports the organizational mission by allowing scientists to reclaim precious research time. Experience concrete business benefits from AI through a solution that is both proven and ready for implementation. Over 41,200 scientists, representing 15 of the top 20 pharmaceutical companies and more than 4,450 academic institutions, rely on BenchSci’s AI-Assisted Antibody Selection to design more effective experiments while achieving significant reductions in hard costs. It’s crucial to recognize that antibodies account for only 40-50% of the reagent-related failures. Gain access to a wealth of experimental evidence, an extensive catalog of reagents and model systems, and independent validations, all within a single intuitive interface. Leverage real-world experimental data sourced from 11.2 million scientific publications, including those often not publicly available, for a comprehensive approach to research. This cutting-edge methodology equips researchers with the tools necessary to make swift and informed decisions, ultimately transforming the landscape of scientific experimentation. By streamlining processes and enhancing data accessibility, the opportunity for breakthroughs in research becomes significantly more attainable.

What is Aiforia?

Aiforia empowers both pathologists and researchers operating in preclinical and clinical lab environments by offering sophisticated deep learning and cloud-based solutions intended to optimize image analysis and improve operational workflows. By enabling researchers to uncover new disease biomarkers, helping R&D scientists to shorten the timelines for the creation of innovative therapies, and assisting pathologists in enhancing accuracy in cancer diagnoses, Aiforia utilizes its deep expertise to transform healthcare from the discovery stage all the way to diagnosis. For clinical pathology labs aiming to increase their productivity and improve diagnostic precision, Aiforia Clinical Suites provide a versatile suite of AI-driven diagnostic tools, advanced visualization capabilities, robust quality control protocols, and automated processes for pre- and post-screening. Moreover, we are currently developing tailored Suites specifically for some of the most prevalent cancers globally and have successfully obtained CE-IVD certification for our AI models targeting lung and breast cancer. As we continue to advance our technology, we remain committed to significantly enhancing patient outcomes while simultaneously optimizing laboratory operations. The potential impact of our innovations extends beyond immediate diagnostics, paving the way for a future of more personalized and effective healthcare solutions.

Media

Media

Integrations Supported

Integrations Supported

Charles River IMS
Microsoft 365
NVIDIA DRIVE

API Availability

API Availability

Pricing Information

Pricing not provided

Pricing Information

Pricing not provided

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

24 Hour Support
Web-Based Support

Customer Service / Support

Standard Support
Web-Based Support

Training Options

Documentation Hub
Online Training
On-Site Training

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Company Facts

Organization Name

BenchSci

Date Founded

2015

Company Location

Canada

Company Website

www.benchsci.com

Company Facts

Organization Name

Aiforia

Company Location

United States

Company Website

www.aiforia.com

Categories and Features

Categories and Features

Pathology

Not specified

Popular Alternatives

Claude Science Reviews & Ratings

Claude Science

Anthropic

Popular Alternatives

The Galen Platform Reviews & Ratings

The Galen Platform

Ibex Medical Analytics
Scitara DLX Reviews & Ratings

Scitara DLX

Scitara
CaseManager DX Reviews & Ratings

CaseManager DX

3DHISTECH